R J Biotech Limited announced earnings results for the half year ended September 30, 2020. For the half year, the company announced total revenue was INR 135.348 million compared to INR 105.623 million a year ago. Net loss was INR 151.594 million compared to INR 39.336 million a year ago. Basic loss per share from continuing operations was INR 16.01 compared to INR 4.15 a year ago.